Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Cancer Type/Condition:  rectal cancer, colon cancer
Trial Type:  Screening, Prevention
Trial Status:  Active
Results 1-25 of 101 for your search:
Start Over
Participation and Detection Rate Diagnostic of a Colorectal Cancer Screening Program: CT Colonography vs. Flexible Sigmoidoscopy
Phase: Phase IV
Type: Screening
Status: Active
Age: 58 to 60
Sponsor: Other
Protocol IDs: 14334-c27.2, NCT01739608
Prevalence of Colon Cancer in Pyogenic Liver Abscess
Phase: Phase IV
Type: Screening
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 1, NCT02032914
The Impact of Warmed Carbon Dioxide Insufflation During Colonoscopy on Polyp Detection
Phase: Phase IV
Type: Diagnostic, Screening
Status: Active
Age: 40 and over
Sponsor: Other
Protocol IDs: 6011440, DMED-1658-13, NCT02065037
Clinical Study-evaluate Performance&Safety "Aer-O-Scope" in Colon of Low Risk Patients
Phase: Phase III, Phase II
Type: Screening
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: 190-CLD-AOS, NCT00867724
The Effects of Vitamin B-6 Status on Homocysteine, Oxidative Stress, One-carbon Metabolism and Methylation: Cross-section, Case-control, Intervention and Follow-up Studies in Colorectal Cancer
Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: S10251, NCT01426490
Study of Folic Acid, Calcium and Vitamin D in Preventing Colorectal Polyps and Colorectal Cancer
Phase: Phase III, Phase II
Type: Prevention
Status: Active
Age: 50 to 80
Sponsor: Other
Protocol IDs: SQ2011SF12RJ, SQ2011SF12-20121010, NCT02066688
The Northern-European Initiative on Colorectal Cancer
Phase: Phase III
Type: Screening
Status: Active
Age: 55 to 64
Sponsor: Other
Protocol IDs: NordICC, NCT00883792
Follow-Up Care With or Without CEA Assessments in Patients Who Have Undergone Surgery for Stage II or Stage III Colorectal Cancer
Phase: Phase III
Type: Natural history/Epidemiology, Screening
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000654114, FFCD-PRODIGE-13, 2009-A00536-51, EU-20979, PRODIGE 13, FFCD 0902, NCT00995202
S0820, Adenoma and Second Primary Prevention Trial
Phase: Phase III
Type: Prevention
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: S0820, U10CA037429, NCI-2012-02067, NCT01349881
Does Endoscope Position Detecting Unit Facilitate a Complete Colonoscopy Examination
Phase: Phase III
Type: Diagnostic, Screening
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CRE-2011.125-T, NCT01434199
Trial of Eflornithine Plus Sulindac in Patients With Familial Adenomatous Polyposis (FAP)
Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: Not specified
Sponsor: Pharmaceutical / Industry
Protocol IDs: CPP-FAP-310, NCT01483144
Comparison of Adenoma Detection Rate Among Water, Carbon Dioxide and Air Methods of Minimal Sedation Colonoscopy
Phase: Phase III
Type: Screening
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: 5130003, LLUMCGI2013, NCT01782014
Acetylsalicylic Acid and Colorectal Cancer Prevention: Exploring the Platelet Function of Its Mechanism of Action
Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention
Status: Approved-not yet active
Age: 18 to 69
Sponsor: Other
Protocol IDs: D-13-01, 2013-004269-15, NCT02125409
Phase III Study Comparing Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 With Trisulfate Bowel Cleansing Solution Using a 2-Day Split-Dosing Regimen in Adults
Phase: Phase III
Type: Screening
Status: Active
Age: 18 to 85
Sponsor: Pharmaceutical / Industry
Protocol IDs: NER1006-01/2014 (NOCT), 29672, NCT02254486
Short Message Service in Colonoscopy Preparation (PERICLES-II-SMS)
Phase: Phase III
Type: Health services research, Screening
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 102014, NCT02272036
Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus MOVIPREP® Using a 2-Day Split-Dosing and 1-Day Morning Split-Dosing Regimens in Adults.
Phase: Phase III
Type: Diagnostic, Screening
Status: Active
Age: 18 to 85
Sponsor: Pharmaceutical / Industry
Protocol IDs: NER1006-02/2014 (MORA), NCT02273167
Low-fiber Diet for Colorectal Cancer Screening Colonoscopy
Phase: Phase III
Type: Screening
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: DIETCOL, NCT02401802
ProtectiScope CS Intended for Diagnostic and Therapeutic Colonoscopy
Phase: Phase II, Phase I
Type: Diagnostic, Screening, Treatment
Status: Approved-not yet active
Age: 18 to 80
Sponsor: Pharmaceutical / Industry
Protocol IDs: CSP-IL-LIT-0703_S_01, NCT00715325
Experimental Device to Improve Colonoscopy
Phase: Phase II, Phase I
Type: Screening
Status: Active
Age: 40 to 80
Sponsor: NIDDK
Protocol IDs: 080173, 08-DK-0173, NCT00719641
Influence of Sulindac and Probiotics on the Development of Pouch Adenomas in Patients With Familial Adenomatous Polyposis
Phase: Phase II
Type: Prevention
Status: Active
Age: 16 and over
Sponsor: Other
Protocol IDs: 23266, KUN 2003-2911, NCT00319007
Acetylsalicylic Acid and Eflornithine in Treating Patients at High Risk for Colorectal Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology, Prevention
Status: Active
Age: 40 to 120
Sponsor: NCI
Protocol IDs: NCI-2009-01192, 09-001758, MC054A, R01-CA-113681, P30CA015083, NCT00983580
Minimizing the Risk of Metachronous Adenomas of the Colorectum With Green Tea Extract -MIRACLE-
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 50 to 80
Sponsor: Other
Protocol IDs: MIRACLE, NCT01360320
Fish Oil Supplementation, Nutrigenomics and Colorectal Cancer Prevention
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 40 to 79
Sponsor: NCI, Other
Protocol IDs: 11165, R01CA160938, NCT01661764
Polyp Detection With The Peerscope System™
Phase: Phase II
Type: Screening
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: CD-1158, NCT01549535
Start Over